Health Care/Hospital

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada

Milestone Coincides with SK Biopharmaceuticals' Global Plan Expanding Cenobamate Access to More Than 100 Markets Worldwide SEOUL, South Korea and ROME, March 12, 2024 /PRNewswire/ -- SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous system (CN...

2024-03-12 08:00 1372

Appointment of Dr Darren Patti to Group Chief Operating Officer

MELBOURNE, Australia, March 12, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr.Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024. Dr. Patti joined Telix in March 2021 to lead the Company'...

2024-03-12 05:44 1330

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of$50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by a...

2024-03-12 04:30 1636

Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London

SHANGHAI, March 11, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present its next generation ADC platform IDDC™ and the latest study results of multiple novel ADCs (9MW2821, 7MW3711, 9MW2921) developed...

2024-03-11 22:00 1113

Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout

BOSTON, March 11, 2024 /PRNewswire/ -- Medicilon, a one-stop pharmaceutical preclinical research and developmentCRO can simultaneously meet Chinese and American drug discovery and development needs (including GLP standards) promptly and efficiently with fast initiation times.Over the past 20 year...

2024-03-11 20:30 1086

ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. ( Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement withHarvard University (Cambridge, MA, USA; "Harvard") aiming at v...

2024-03-11 20:00 1147

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...

2024-03-11 20:00 1029

ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results

SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- ImmunAbs, a leading clinical-stage biotechnology company focused on developing novel antibody therapeutics, today announced the successful completion of the Phase 1 clinical trial for IM-101. IM-101 is a humanized monoclonal antibody targeting...

2024-03-11 17:00 1784

AirNet Announces Changes in the Board of Directors

BEIJING, March 11, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. (the "Company") (Nasdaq: ANTE), today announced changes in its board of directors (the "Board"). Mr. Dong Wen has tendered resignation as an independent director of the Company, a member of the ...

2024-03-11 16:00 1123

Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry

SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place fromApril 11th to 14th in Shanghai. The industry-leading tradeshow will draw nearly 5,000 global exhibitors from over 20 countries, with an expected audience of over 200,...

2024-03-11 15:20 1562

AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery

HONG KONG, March 11, 2024 /PRNewswire/ -- As artificial intelligence technology continues to advance, it has accelerated intelligent innovation across various industries. Breakthroughs in AI technologies like GPT have gained widespread attention, especially in the healthcare sector, where they of...

2024-03-11 15:06 1354

Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care

NEW DELHI, March 11, 2024 /PRNewswire/ -- Apollo Hospitals becomes the first hospital to introduce ZAP-X Gyroscopic Radiosurgery Platform, a significant milestone as the first inSouth Asia to introduce this ground-breaking technology. ZAP-X introduces a new era in brain tumor treatment, offering ...

2024-03-11 15:00 1434

Fullerton Health Deepens Commitment to Community Health with Health Hub Clinics in the Heartlands

SINGAPORE, March 11, 2024 /PRNewswire/ -- In line with Fullerton Health's purpose of affordable and accessible care for all, residents living in Hougang will now be able to enjoy the full range of primary care , preventive health and diagnostic services closer to home at Fullerton Health Hub @ Ho...

2024-03-11 14:00 1345

This World Oral Health Day, Sensodyne introduces NEW Triple Action Formula: 'Sensitivity Gum & Enamel'

* Sensodyne has expanded its fastest growing Advanced range of Sensitivity and Gum with its latest innovation that helps relieve Sensitivity, restore Gum Health & strengthen Enamel. * All-year round NEW awareness campaign to educate consumers on the importance of dealing with Enamel erosion a...

2024-03-11 13:23 1296

FWD Group completes additional investment in Malaysia; becomes majority shareholder in FWD Takaful Berhad

KUALA LUMPUR, Malaysia, March 11, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced the completion of an additional investment for a further 21 percent stake in FWD Takaful Berhad ("FWD Takaful"). FWD is now the majority shareholder in FWD Takaful, with a 70...

2024-03-11 11:41 1510

RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024

YANTAI, China, March 11, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an interim analysis of the evaluation of the Company's proprietary Disitamab ...

2024-03-11 10:36 1282

APPIS 2024: Healthcare Stakeholders Come Together to Prioritize Action for Better Patient Outcomes in Asia Pacific, Middle East, and Africa

* Since 2021, the APPIS platform has brought together over 2,000 people from more than 65 countries to address barriers to healthcare access. * Over 40 healthcare expert speakers will cover critical topics from health literacy, health policy shaping and future readiness at the APPIS Summit 202...

2024-03-11 10:00 1709

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau

-- Macau is on course to become the first of Everest's Asian territories to get etrasimod approval -- Can provide access to patients in China's Greater Bay area and rest of Asia SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceu...

2024-03-11 09:00 2187

Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting

HANGZHOU and SHAOXING, China, March 10, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the poster presentation of Phase II study final results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the 2024 American Academy of...

2024-03-11 08:10 995

Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development

HONG KONG, March 9, 2024 /PRNewswire/ -- In 2019, the HKSAR Government officially launched the Chinese Medicine Development Fund (CMDF) to promote the development and elevate the overall standards of the Chinese medicine (CM) sector inHong Kong. Starting from today, the CMDF will host a four-day ...

2024-03-09 18:17 2438
12345678 ... 800